Cargando…
One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice
Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology re...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138433/ https://www.ncbi.nlm.nih.gov/pubmed/30087111 http://dx.doi.org/10.15252/embj.201899243 |
_version_ | 1783355346390089728 |
---|---|
author | Lin, Ying‐Cing Pecetta, Simone Steichen, Jon M Kratochvil, Sven Melzi, Eleonora Arnold, Johan Dougan, Stephanie K Wu, Lin Kirsch, Kathrin H Nair, Usha Schief, William R Batista, Facundo D |
author_facet | Lin, Ying‐Cing Pecetta, Simone Steichen, Jon M Kratochvil, Sven Melzi, Eleonora Arnold, Johan Dougan, Stephanie K Wu, Lin Kirsch, Kathrin H Nair, Usha Schief, William R Batista, Facundo D |
author_sort | Lin, Ying‐Cing |
collection | PubMed |
description | Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology relies on Cas9 nuclease‐induced double‐stranded breaks directed by two sgRNAs to occur within the specific target locus of fertilized oocytes. These double‐stranded breaks are subsequently repaired via homology‐directed repair by a plasmid‐borne template containing the pre‐arranged human immunoglobulin heavy chain. To validate our knock‐in mouse model, we examined the expression of the KI immunoglobulin heavy chains by following B‐cell development and performing single B‐cell receptor sequencing. We optimized this strategy to generate immunoglobulin KI mice in a short amount of time with a high frequency of homologous recombination (30–50%). In the future, we envision that such knock‐in mice will provide much needed vaccination models to evaluate immunoresponses against immunogens specific for various infectious diseases. |
format | Online Article Text |
id | pubmed-6138433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-61384332018-09-15 One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice Lin, Ying‐Cing Pecetta, Simone Steichen, Jon M Kratochvil, Sven Melzi, Eleonora Arnold, Johan Dougan, Stephanie K Wu, Lin Kirsch, Kathrin H Nair, Usha Schief, William R Batista, Facundo D EMBO J Resource Here, we describe a one‐step, in vivo CRISPR/Cas9 nuclease‐mediated strategy to generate knock‐in mice. We produced knock‐in (KI) mice wherein a 1.9‐kb DNA fragment bearing a pre‐arranged human B‐cell receptor heavy chain was recombined into the native murine immunoglobulin locus. Our methodology relies on Cas9 nuclease‐induced double‐stranded breaks directed by two sgRNAs to occur within the specific target locus of fertilized oocytes. These double‐stranded breaks are subsequently repaired via homology‐directed repair by a plasmid‐borne template containing the pre‐arranged human immunoglobulin heavy chain. To validate our knock‐in mouse model, we examined the expression of the KI immunoglobulin heavy chains by following B‐cell development and performing single B‐cell receptor sequencing. We optimized this strategy to generate immunoglobulin KI mice in a short amount of time with a high frequency of homologous recombination (30–50%). In the future, we envision that such knock‐in mice will provide much needed vaccination models to evaluate immunoresponses against immunogens specific for various infectious diseases. John Wiley and Sons Inc. 2018-08-07 2018-09-14 /pmc/articles/PMC6138433/ /pubmed/30087111 http://dx.doi.org/10.15252/embj.201899243 Text en © 2018 The Authors Open access. |
spellingShingle | Resource Lin, Ying‐Cing Pecetta, Simone Steichen, Jon M Kratochvil, Sven Melzi, Eleonora Arnold, Johan Dougan, Stephanie K Wu, Lin Kirsch, Kathrin H Nair, Usha Schief, William R Batista, Facundo D One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title | One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title_full | One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title_fullStr | One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title_full_unstemmed | One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title_short | One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
title_sort | one‐step crispr/cas9 method for the rapid generation of human antibody heavy chain knock‐in mice |
topic | Resource |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138433/ https://www.ncbi.nlm.nih.gov/pubmed/30087111 http://dx.doi.org/10.15252/embj.201899243 |
work_keys_str_mv | AT linyingcing onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT pecettasimone onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT steichenjonm onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT kratochvilsven onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT melzieleonora onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT arnoldjohan onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT douganstephaniek onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT wulin onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT kirschkathrinh onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT nairusha onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT schiefwilliamr onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice AT batistafacundod onestepcrisprcas9methodfortherapidgenerationofhumanantibodyheavychainknockinmice |